Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228345 · ClinicalTrials.gov registry record · Phase 1
The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
A Phase 1 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00228345 is a Phase 1 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 40 participants.
The verdict
NCT00228345, a Phase 1 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether impaired glucose handling (abnormality in the way the body processes blood sugar) can cause a neuropathy (damage to the nerves).
Interventions
- PROCEDURE Optical coherence tomography,Fluorescein angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228345
The ClinicalTrials.gov registry entry for NCT00228345 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical coherence tomography,Fluorescein angiography is the first listed.
NCT00228345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228345 about?
NCT00228345 is a clinical study titled "The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy". The purpose of this study is to determine whether impaired glucose handling (abnormality in the way the body processes blood sugar) can cause a neuropathy (damage to the nerves).
What is the current status of trial NCT00228345?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2004-01. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00228345?
The interventions under investigation include: Optical coherence tomography,Fluorescein angiography (PROCEDURE).
Who is sponsoring clinical trial NCT00228345?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.